AKEBIA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.26 USD | -4.55% |
|
-8.03% | +1.61% |
| Apr. 23 | Averoa Seeks EU Approval for Chronic Kidney Disease Drug | MT |
| Apr. 16 | Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited Enters into Second Amendment to the Supply Agreement | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-25 | 2024-04-26 | 2024-04-29 | 2024-04-30 | |
|---|---|---|---|---|
| Last | 1.33 $ | 1.34 $ | 1.32 $ | 1.26 $ |
| Volume | 2 561 124 | 2 475 964 | 1 974 332 | 4 653 593 |
| Change | -2.92% | +0.75% | -1.49% | -4.55% |
| Opening | 1.35 | 1.32 | 1.34 | 1.31 |
| High | 1.35 | 1.35 | 1.38 | 1.32 |
| Low | 1.31 | 1.29 | 1.31 | 1.23 |
Performance
| 1 day | -4.55% | ||
| 1 week | -8.03% | ||
| 1 month | -31.15% | ||
| 3 months | -25.00% | ||
| 6 months | +43.18% | ||
| Current year | +1.61% | ||
| 1 year | +38.69% | ||
| 3 years | -60.50% | ||
| 5 years | -79.14% | ||
| 10 years | -94.83% |
Volumes
marketsDaily volume
4 653 593
Estimated daily volume
4 653 593
Avg. Volume 20 sessions
3 030 194
Daily volume ratio
1.54
Avg. Volume 20 sessions USD
3 818 044.44
Record volume 1
84 387 410
Record volume 2
81 420 240
Record volume 3
81 393 290
Capital turnover ratio
0.01
Float rotation
0.02
Basic data
Capitalization (USD)
263 809 066
Net sales (USD)
194 623 000
Number of employees
167
Sales / Employee (USD)
1 165 407
Free-Float
90.33 %
Free-Float capitalization (USD)
238 563 871
Average Daily Capital Traded
1.45%
Highs and lows
1 week
1.23
1.38
1 month
1.231.62
Current year
1.212.48
1 year
0.782.48
3 years
0.244.33
5 years
0.2413.71
10 years
0.2431.00
Indicators
Moving average 5 days
1.32
Moving average 20 days
1.44
Moving average 50 days
1.57
Moving average 100 days
1.49
Price spread / (MMA5)
+5.08%
Price spread / (MMA20)
+13.89%
Price spread / (MMA50)
+24.57%
Price spread / (MMA100)
+18.23%
STIM
RSI 9 days
29.85
RSI 14 days
36.68
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -4.55% | -8.03% | +1.61% | +38.69% | 264M | ||
| -0.86% | -2.99% | -3.46% | +15.28% | 102B | ||
| -0.20% | -1.84% | +1.41% | +11.08% | 96.09B | ||
| +0.66% | +4.06% | +2.13% | +0.60% | 22.28B | ||
| +0.99% | +0.37% | -15.84% | -22.25% | 21.4B | ||
| -0.69% | -3.62% | -9.21% | -29.62% | 18.14B | ||
| -2.02% | +3.73% | -39.98% | -35.33% | 17.02B | ||
| -1.65% | +10.76% | -14.65% | -39.62% | 16.09B | ||
| -0.97% | -1.82% | +4.39% | +36.12% | 13.83B | ||
| -1.66% | +8.15% | +31.35% | +3.17% | 11.97B | ||
| +5.52% | +22.56% | +327.62% | +273.44% | 8.78B | ||
| -3.10% | -7.82% | -27.31% | -36.34% | 7.96B | ||
| -1.22% | -4.41% | +9.92% | +97.88% | 7.91B | ||
| -0.09% | +1.71% | +0.73% | +47.07% | 7.76B | ||
| -1.58% | +7.34% | -53.58% | -70.42% | 7.31B | ||
| -1.14% | +0.73% | -2.21% | +28.20% | 6.92B | ||
| Average | -1.22% | +1.61% | +13.31% | +19.87% | ||
| Weighted average by Cap. | -0.67% | -0.10% | +3.23% | +10.56% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
90.4cIMBfFb87gq3aYHjLo7H38u8dNtqJC_vj7oQJ0IXfA.lrJnTcUTpNF8juFF1vtQTjNXkpErycDM0V2jEcJtE7WJiW83tG2S4BqY5w
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 1.26 | 49,356 | 4,437,298 |
| 03:59:56 pm | 1.26 | 224 | 4,387,942 |
| 03:59:55 pm | 1.255 | 100 | 4,387,718 |
| 03:59:55 pm | 1.26 | 300 | 4,387,618 |
| 03:59:55 pm | 1.256 | 300 | 4,387,318 |
| 03:59:54 pm | 1.26 | 100 | 4,387,018 |
| 03:59:54 pm | 1.26 | 100 | 4,386,918 |
| 03:59:54 pm | 1.26 | 206 | 4,386,818 |
| 03:59:54 pm | 1.26 | 200 | 4,386,612 |
| 03:59:54 pm | 1.26 | 300 | 4,386,412 |
Monthly variations
Annual change
| 2024 | +1.61% | ||
| 2023 | +114.90% | ||
| 2022 | -74.47% | ||
| 2021 | -19.29% | ||
| 2020 | -55.70% | ||
| 2019 | +14.29% | ||
| 2018 | -62.81% | ||
| 2017 | +42.84% | ||
| 2016 | -19.43% | ||
| 2015 | +11.00% | ||
| 2014 | -56.40% |
- Stock Market
- Equities
- AKBA Stock
- Quotes Akebia Therapeutics, Inc.
